73
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Pedunculopontine nucleus stimulation for people with Parkinson's disease? A clinical perspective

Pages S13-S15 | Published online: 06 Jul 2009

References

  • Aziz T Z, Peggs D, Sambrook M A. Crossman Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991; 6(4)288–92
  • Hariz M I, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry 2008; 79: 694–9
  • Kleiner-Fisman G, Herzog J, Fisman D N, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21(Suppl 14)S290–304
  • Deuschl G, Schade-Brittinger C, Krack P, et al. with the German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896–908
  • Esselink R A, de Bie R M, de Haan R J, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multicentre trial. Acta Neurochir (Wien) 2006; 148: 1247–55.
  • Wider C, Pollo C, Bloch J, Burkhard P R, Vingerhoets F J. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008; 14: 114–19
  • Pahwa R, Factor S A, Lyons K E, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66: 983–95
  • Derost P P, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population. Neurology 2007; 68(17)1345–55
  • Hariz M I, Rehncrona S, Quinn N P, Speelman J D, Wensing C. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years. Mov Disord 2008; 23: 416–21
  • Yamada K, Goto S, Hamasaki T, Kuratsu J I. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Acta Neurochir (Wien) 2008; 150: 15–22
  • Visser J E, Allum J H, Carpenter M G, et al. Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease. J Neurol 2008; 255: 205–10
  • Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiat 1988; 51: 540–3
  • Rinne J O, Ma S Y, Lee M S, Collan Y, Röyttä M. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord 2008; 14: 553–557
  • Nandi D, Aziz T Z, Giladi N, Winter J, Stein J F. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 2002; 125: 2418–30
  • Jenkinson N, Nandi D, Miall R C, Stein J F, Aziz T Z. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 2004; 15: 2621–4
  • Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005; 16: 1877–81
  • Plaha P, Gill S S. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005; 16: 1883–7
  • Stefani A, Lozano A M, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130: 1596–607
  • Zrinzo L, Zrinzo L V, Tisch S, et al. Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain 2008; 131: 1588–1598

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.